Total Payments
$3,363
2024 Payments
$852.50
Companies
17
Transactions
56
Medicare Patients
186
Medicare Billing
$24,629
Payment Breakdown by Category
Food & Beverage$3,143 (93.5%)
Education$153.82 (4.6%)
Other$65.95 (2.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,143 | 51 | 93.5% |
| Education | $153.82 | 2 | 4.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $65.95 | 3 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vifor Pharma, Inc. | $614.83 | 6 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $535.55 | 11 | $0 (2024) |
| CALLIDITAS THERAPEUTICS US INC. | $326.15 | 4 | $0 (2024) |
| OPKO Pharmaceuticals, LLC | $236.35 | 7 | $0 (2023) |
| PFIZER INC. | $232.99 | 2 | $0 (2019) |
| Amgen Inc. | $227.81 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $204.97 | 2 | $0 (2020) |
| Bayer Healthcare Pharmaceuticals Inc. | $170.29 | 5 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $146.42 | 3 | $0 (2020) |
| Aurinia Pharma U.S., Inc. | $131.93 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $852.50 | 20 | AstraZeneca Pharmaceuticals LP ($400.89) |
| 2023 | $847.56 | 19 | OPKO Pharmaceuticals, LLC ($236.35) |
| 2022 | $872.94 | 8 | Vifor Pharma, Inc. ($474.45) |
| 2021 | $205.70 | 2 | SANOFI-AVENTIS U.S. LLC ($118.58) |
| 2020 | $268.40 | 4 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($146.42) |
| 2019 | $315.98 | 3 | PFIZER INC. ($232.99) |
All Payment Transactions
56 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.37 | General |
| Category: NEPHROLOGY | ||||||
| 11/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Vifor Pharma, Inc. | — | Food and Beverage | In-kind items and services | $17.07 | General |
| 10/02/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $105.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $97.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $47.55 | General |
| Category: Nephrology | ||||||
| 07/11/2024 | Baxter Healthcare | Renal - Acute (Device) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: Renal | ||||||
| 07/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: NEPHROLOGY | ||||||
| 05/30/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $97.31 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), LOKELMA | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/07/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $115.37 | General |
| Category: Nephrology | ||||||
| 04/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: Cardio-renal | ||||||
| 04/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/04/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Cardio-renal | ||||||
| 11/02/2023 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $86.50 | General |
| Category: KRYSTEXXA | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/04/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/28/2023 | Calliditas Therapeutics US Inc. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $64.88 | General |
| Category: Nephrology | ||||||
| 09/27/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 186 | 269 | $62,403 | $24,629 |
Total Patients
186
Total Services
269
Medicare Billing
$24,629
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 104 | $25,688 | $9,684 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 50 | 50 | $16,000 | $5,873 | 36.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 24 | 61 | $12,017 | $5,403 | 45.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 18 | 41 | $5,617 | $2,413 | 43.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 11 | 13 | $3,081 | $1,255 | 40.7% |
About Dr. Rohan Kataria, M.D
Dr. Rohan Kataria, M.D is a Nephrology healthcare provider based in Cookeville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2018. The National Provider Identifier (NPI) number assigned to this provider is 1821587353.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rohan Kataria, M.D has received a total of $3,363 in payments from pharmaceutical and medical device companies, with $852.50 received in 2024. These payments were reported across 56 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($3,143).
As a Medicare-enrolled provider, Kataria has provided services to 186 Medicare beneficiaries, totaling 269 services with total Medicare billing of $24,629. Data is available for 1 year (2023–2023), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Cookeville, TN
- Active Since 05/10/2018
- Last Updated 01/29/2026
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1821587353
Products in Payments
- TARPEYO (Drug) $326.15
- ELIQUIS (Drug) $316.61
- FARXIGA (Drug) $315.45
- Veltassa (Drug) $245.92
- RAYALDEE (Drug) $236.35
- KRYSTEXXA (Biological) $183.81
- Kerendia (Drug) $170.29
- LifeVest (Device) $146.42
- LOKELMA (Drug) $132.98
- LUPKYNIS (Drug) $131.93
- Korsuva (Drug) $123.31
- VYNDAQEL (Drug) $121.35
- THYMOGLOBULIN (Biological) $118.58
- Korlym (Drug) $87.75
- JYNARQUE (Drug) $44.95
- Ozempic (Drug) $32.27
- Renal - Acute (Device) $27.68
- TAVNEOS (Drug) $19.13
- Gambro - Accute (Device) $18.38
- ULTOMIRIS (Biological) $13.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.